Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

PDA Container Closure Integrity Testing Training Course

Apr 19 - Apr 20, 2018 |
Apr 20, 2018 |
Imperial Palace Seoul | Seoul, Korea
  • Education
  • Asia-Pacific
  • Western Hemisphere Events
Add event to: ICal Outlook Google Calendar
Information coming soon.

Thursday, 19-April | 9:00 – 17:30

Friday, 20-April | 9:00 – 16:00

  • Regulatory Requirements
  • Container closure Integrity (CCI) assurance through product life cycle
  • CCI methods, fundamentals, and overview
  • Advanced CCI testing methods
    • Vacuum and pressure decay
    • Headspace analytics
    • HVLD
    • Tracer gas methods
    • Seal quality testing (e.g., residual seal force)
  • Selection of test methods
  • Development and validation of methods
  • Application case studies
  • Hands-on exercises with equipment for the different methods
  • Interactive Q&A with discussions, you can bring your sample and share or problems






Government/Health Authority/Academic





Student Member





Young Professional Member



All prices in US dollars.

*For this member type or discounted rate, online registration is not available and must be faxed in.

You must be a member to take advantage of this rate.

REFUND FOR COURSES: If your written request is received by March 30, 2018, you will receive a full refund less a $200 processing fee. After that time, no refunds will be approved. COURSE CANCELLATION: PDA reserves the right to modify the material or instructors without notice, or to cancel an event. If an event must be cancelled, registrants will be notified by PDA as soon as possible and will receive a full refund. PDA will not be responsible for airfare penalties or other costs incurred due to cancellation. For more details, contact PDA at or +1 (301) 656-5900.


Molly O'Neill Moir, CMP
Vice President, Programs & Meetings
Tel: (301) 656-5900 ext. 132

Lei Li, PhD, Associate Engineer Advisor Delivery and Device R&D, Eli Lilly and Company

Lei Li currently serves as an engineer advisor at Delivery and Device R&D, Eli Lilly and Company. Lei has 9 years of experience in pharmaceutical and medical device industry, with focus on developing API and drug product packaging in support of clinical development and product commercialization, and establishing cold-chain distribution for biologic products. His current responsibilities include developing package integrity verification profiles for Lilly’s diverse pipeline portfolio, developing and validating CCI testing methods, and supporting commercial control strategy development for CCI verification throughout drug product and device life cycle. He is a frequent speaker at PDA conferences and author of peer-reviewed articles and book chapters on CCI test methods. Lei Li received his PhD in Analytical Chemistry from West Virginia University; prior to joining Eli Lilly, he worked at GE Plastics as an analytical and material scientist.

Information coming soon.
Register Now